Clinical Study

No Difference in Sleep and RBD between Different Types of Patients with Multiple System Atrophy: A Pilot Video-Polysomnographical Study

Table 2

Polysomnographic characteristics of MSA-C and MSA-P patients.

MSA-C ( )MSA-P ( )Significance value

Sleep efficiency, %64.27 ± 12.0460.64 ± 16.01NS
Sleep latency, min 25.74 ± 17.3329.76 ± 41.54NS
Sleep stage 1, % of TST 23.47 ± 8.4626.63 ± 9.84NS
Sleep stage 2, % of TST 52.15 ± 8.6747.55 ±14.61NS
Sleep stage 3, % of TST4.70 ± 6.708.58 ± 11.55NS
Sleep REM, % of TST19.68 ± 9.8417.24 ± 11.08NS
REM latency, min123.09 ± 81.62141.72 ± 103.93NS
Awakenings, total18.09 ± 9.2723.69 ± 8.24NS
Awakenings index/h4.01 ± 1.965.83 ± 3.75NS
PLM index64 ± 5561 ± 48NS
PLMS index72 ± 6566 ± 63NS
PLMW index 38 ± 3348 ± 37NS
RLS-like, (%)3 (30.77)8 (27.27)NS

TST: total sleep time. Sleep efficiency was calculated as % of sleep during time in bed; sleep stages were calculated as % of TST; index of periodic leg movements (PLM) was calculated per hour of time in bed (PLM index), per hour of sleep (PLMS index), and per hour of wakefulness (PLMW index), awakening index = total number of awakenings in TST, RLS-like: restless legs symptoms, MSA-C: multiple system atrophy cerebellar predominant, MSA-P: multiple system atrophy parkinsonian predominant, NS: nonsignificant ( value > 0.05).